propionylcarnitine has been researched along with Insulin Sensitivity in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, C; Dennison, EM; Edwards, MH; Geisendorfer, T; Huber, A; Jarvelin, MR; Karhunen, V; Menni, C; Metrustry, SJ; Reichel, C; Spector, T; Valdes, AM | 1 |
Alvarez de Sotomayor, M; Dolores Herrera, M; Gonzalez del Pozo, M; Mingorance, C | 1 |
Alvarez de Sotomayor, M; Herrera, MD; Justo, ML; Mingorance, C; RodrÃguez-RodrÃguez, R | 1 |
de Sotomayor, MA; Herrera, MD; Justo, ML; Mingorance, C; Rodriguez-Rodriguez, R | 1 |
2 review(s) available for propionylcarnitine and Insulin Sensitivity
Article | Year |
---|---|
Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.
Topics: Acetylcarnitine; Animals; Cardiovascular Agents; Cardiovascular Diseases; Carnitine; Diabetes Mellitus, Type 2; Evidence-Based Medicine; Humans; Hypoglycemic Agents; Insulin Resistance; Treatment Outcome | 2011 |
Pharmacological effects and clinical applications of propionyl-L-carnitine.
Topics: Adenosine Triphosphate; Atherosclerosis; Carbohydrate Metabolism; Cardiotonic Agents; Carnitine; Endothelium; Free Radical Scavengers; Heart; Humans; Insulin Resistance; Lipid Metabolism; Oxidative Stress | 2011 |
2 other study(ies) available for propionylcarnitine and Insulin Sensitivity
Article | Year |
---|---|
Metabolomic signatures of low birthweight: Pathways to insulin resistance and oxidative stress.
Topics: Adolescent; Adult; Aged; Carnitine; Cohort Studies; Dipeptides; Female; Fetal Growth Retardation; Finland; Humans; Hydroxybutyrates; Infant, Low Birth Weight; Infant, Newborn; Insulin Resistance; Male; Metabolome; Metabolomics; Middle Aged; Oxidative Stress; Phenylpropionates; Pregnancy; Sex Factors; Twins; United Kingdom; Young Adult | 2018 |
Oral supplementation of propionyl-l-carnitine reduces body weight and hyperinsulinaemia in obese Zucker rats.
Topics: Animals; Carnitine; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Endothelium, Vascular; Glucose Tolerance Test; Hemodynamics; Hyperinsulinism; Insulin Resistance; Lipids; Metabolic Syndrome; Obesity; Rats; Rats, Zucker; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Weight Gain | 2009 |